With the last regulatory hurdle cleared, Prospect will pay $300 million for Crozer-Keystone. That figure includes up to $120 million in pension fund liabilities, $15 million in liability insurance coverage and the assumption of $160 million in long-term debt obligations, according to the Philadelphia Business Journal.
Prospect and Crozer-Keystone inked a definitive agreement in January. Under the deal, Crozer-Keystone’s five hospitals, its physician network and other facilities will become part of the Prospect Network.
More articles on healthcare industry transactions:
7 recent hospital transactions and partnerships
FTC approves ProMedica’s plan to spin off St. Luke’s as independent hospital
Duke LifePoint eyes acquisition of Good Shepherd Health System
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
